EPISODE · Dec 2, 2020 · 9 MIN
GRACEcast - LCVL - Which patients with advanced NSCLC are good candidates for first line immunotherapy alone today
from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE
Dr H. Jack West discusses Immunotherapy in NSCLC, and which patients with advanced NSCLC are good candidates for first line immunotherapy alone today?
Embed this episode
NOW PLAYING
GRACEcast - LCVL - Which patients with advanced NSCLC are good candidates for first line immunotherapy alone today
0:00
9:26
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of GRACEcast - Discussions with the Global Resource for Advancing Cancer Education?
This episode is 9 minutes long.
When was this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode published?
This episode was published on December 2, 2020.
Can I download this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!